CN115478118A - Taqman multiplex fluorescence quantitative PCR (polymerase chain reaction) detection method for porcine circovirus - Google Patents
Taqman multiplex fluorescence quantitative PCR (polymerase chain reaction) detection method for porcine circovirus Download PDFInfo
- Publication number
- CN115478118A CN115478118A CN202210741678.XA CN202210741678A CN115478118A CN 115478118 A CN115478118 A CN 115478118A CN 202210741678 A CN202210741678 A CN 202210741678A CN 115478118 A CN115478118 A CN 115478118A
- Authority
- CN
- China
- Prior art keywords
- seq
- sequence
- probe
- pcv1
- pcv2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003753 real-time PCR Methods 0.000 title claims abstract description 41
- 241000202347 Porcine circovirus Species 0.000 title claims abstract description 32
- 238000001514 detection method Methods 0.000 title claims abstract description 22
- 238000003752 polymerase chain reaction Methods 0.000 title description 13
- 239000000523 sample Substances 0.000 claims abstract description 83
- 238000000034 method Methods 0.000 claims abstract description 37
- 238000006243 chemical reaction Methods 0.000 claims description 25
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 18
- 241001673669 Porcine circovirus 2 Species 0.000 claims description 17
- 238000011144 upstream manufacturing Methods 0.000 claims description 8
- 238000011529 RT qPCR Methods 0.000 claims description 6
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 241001661006 Pepper cryptic virus 2 Species 0.000 abstract 1
- 230000003321 amplification Effects 0.000 description 20
- 238000003199 nucleic acid amplification method Methods 0.000 description 20
- 239000000126 substance Substances 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 7
- 238000000137 annealing Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000701386 African swine fever virus Species 0.000 description 4
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 description 4
- 241000702619 Porcine parvovirus Species 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 238000007400 DNA extraction Methods 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 3
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 241001504639 Alcedo atthis Species 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 101150009852 ORF2 gene Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000702665 Porcine rotavirus Species 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000011999 immunoperoxidase monolayer assay Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000007403 mPCR Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241001533399 Circoviridae Species 0.000 description 1
- 241001533384 Circovirus Species 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102100038353 Gremlin-2 Human genes 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101001032860 Mus musculus Gremlin-2 Proteins 0.000 description 1
- 208000005119 Necrotizing Pneumonia Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 241001504982 Pepper cryptic virus 1 Species 0.000 description 1
- 241000928435 Porcine circovirus 1 Species 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000010399 Wasting Syndrome Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The application provides a porcine circovirus Taqman multiplex fluorescence quantitative PCR detection method and a corresponding detection kit thereof, wherein primers and probes which are designed aiming at PCV1, PCV-2, PCV-3 and PCV-4 and have sequences of SEQ ID NO.1-12 are used in the method and the kit. The method and the kit have comprehensive detection objects, complete detection in one step in a 4-fold Taqman multiplex fluorescence quantitative PCR, and have good sensitivity and specificity.
Description
The invention belongs to the field of the invention:
the application belongs to the technical field of molecular biology detection, and particularly provides a porcine circovirus Taqman multiplex fluorescence quantitative PCR detection method and a corresponding detection kit thereof.
The background art comprises the following steps:
porcine Circovirus (PCV) is an unencapsulated, single-stranded, closed circular DNA virus of the genus circovirus of the family circoviridae, with virions in a regular icosahedral symmetric structure, about 17-22nm in diameter, and about 1.7-2.0kb in whole genome size, and is one of the smallest animal viruses currently known. The porcine circovirus is subdivided into four genotypes according to the difference of nucleotide homology, namely porcine circovirus type 1 (PCV 1), porcine circovirus type 2 (PCV 2), porcine circovirus type 3 (PCV 3) and porcine circovirus type 4 (PCV 4). PCV1 was first discovered in 1974 and was originally identified as a PK15 porcine kidney cell line contaminant, but was not pathogenic; PCV2 and PCV3 were isolated and identified in 1991 and 2016, respectively, and were both highly susceptible to pigs, and clinically caused Postweaning multi-system wasting Syndrome (PMWS), porcine Dermatitis Nephrotic Syndrome (PDNS), porcine respiratory disease Syndrome (PRDC), and Porcine Proliferative and Necrotizing Pneumonia (PNP). These diseases are collectively referred to as Porcine circovirus disease (PCVD) or Porcine circovirus associated disease (PCVAD); PCV4 is first discovered in Hunan province in 2019 in China, and the pathogenicity of PCV4 is not clear. Porcine circovirus usually causes severe immunosuppression of organisms, presents multiple pathogen mixed infection clinically, and has great harm to the pig industry, so that the porcine circovirus is particularly important for differential diagnosis of the porcine circovirus in the prevention and treatment process.
The porcine circovirus infected with different genotypes has similar clinical symptoms and pathological changes, is usually mixed infection of various pathogens, and is difficult to make accurate judgment simply by means of clinical diagnosis and pathological section. The results of the molecular level diagnosis in the laboratory are therefore usually further confirmed as gold standards, i.e.by detection of pathogens by molecular biological methods and by detection of serum-neutralizing antibodies by serological methods. The molecular biology method mainly comprises the following steps: polymerase Chain Reaction (PCR) and in situ nucleic acid hybridization assay (ISH); the serological method mainly comprises the following steps: enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence assay (IFA), immunohistochemical assay (IHC), immunoperoxidase monolayer assay (IPMA), agar test, colloidal gold immunochromatography assay, and the like. Although the methods described above are numerous, the most widely used and most studied methods are currently the PCR and ELISA methods. In the prior art, various PCR detection methods for PCV1-3 exist.
The in vitro diagnostic technique of PCV1-3, especially PCV2 and PCV3, has been studied relatively well, but there are few reports on all members of porcine circovirus, i.e. in vitro diagnostic methods for detecting PCV1-4 simultaneously. The method for establishing the rapid and effective TaqMan multiplex real-time fluorescence quantitative PCR method for PCV1-4 type can efficiently and rapidly detect early infectors and recessive carriers in swinery, provides help for mastering PCV epidemic situation and subsequent PCV prevention and control purification, and has great significance.
Disclosure of Invention
In view of the above, in one aspect, the present application provides a Taqman multiplex fluorescence quantitative PCR detection method for porcine circovirus for non-diagnostic use, the method comprising performing Taqman multiplex fluorescence quantitative PCR using the following primers: PCV1-F with a sequence of SEQ ID NO.1, PCV2-F with a sequence of SEQ ID NO.4, PCV3-F with a sequence of SEQ ID NO.7, PCV4-F with a sequence of SEQ ID NO.10, PCV1-R with a sequence of SEQ ID NO.2, PCV2-R with a sequence of SEQ ID NO.5, PCV3-R with a sequence of SEQ ID NO.8 and PCV4-R with a sequence of SEQ ID NO. 11.
Further, the following probes are also used in the Taqman multiplex fluorescence quantitative PCR: PCV1-Probe with the sequence of SEQ ID NO.3, PCV2-Probe with the sequence of SEQ ID NO.6, PCV3-Probe with the sequence of SEQ ID NO.9 and PCV4-Probe with the sequence of SEQ ID NO. 12.
Further, the 5 'end and the 3' end of the probe are respectively marked with the following fluorescent groups: PCV1-Probe: CY5 and BHQ-2, PCV2-Probe: FAM and BHQ-2, PCV3-Probe: HEX-BHQ1, PCV4-Probe: ROX and BHQ-2.
Further, the Taqman multiplex fluorescence quantitative PCR reaction system is 20 mu: 2X T5 Fast qPCR Mix 10. Mu.L, 10. Mu.M PCV1, 3, 4 upstream primer 0.1. Mu.L each, 10. Mu.M PCV1, 3, 4 downstream primer 0.1. Mu.L each, 10. Mu.M PCV2 upstream primer 0.3. Mu.L, 10. Mu.M PCV2 downstream primer 0.3. Mu.L, 10. Mu.M probe 0.02. Mu.L each, template DNA 0.5. Mu.L, ddH 2 O 8.22μL。
Further, the Taqman multiplex fluorescence quantitative PCR reaction program is as follows: 5min at 95 ℃; 30 cycles of 95 ℃ for 10s and 61 ℃ for 50 s.
On the other hand, the application provides a porcine circovirus Taqman multiplex fluorescence quantitative PCR kit, which comprises the following primers: PCV1-F with a sequence of SEQ ID NO.1, PCV2-F with a sequence of SEQ ID NO.4, PCV3-F with a sequence of SEQ ID NO.7, PCV4-F with a sequence of SEQ ID NO.10, PCV1-R with a sequence of SEQ ID NO.2, PCV2-R with a sequence of SEQ ID NO.5, PCV3-R with a sequence of SEQ ID NO.8 and PCV4-R with a sequence of SEQ ID NO. 11.
Further, the kit further comprises the following probes: PCV1-Probe with the sequence of SEQ ID NO.3, PCV2-Probe with the sequence of SEQ ID NO.6, PCV3-Probe with the sequence of SEQ ID NO.9 and PCV4-Probe with the sequence of SEQ ID NO. 12.
Further, the 5 'end and the 3' end of the probe are respectively marked with the following fluorescent groups: PCV1-Probe: CY5 and BHQ-2, PCV2-Probe: FAM and BHQ-2, PCV3-Probe: HEX-BHQ1, PCV4-Probe: ROX and BHQ-2.
Further, the kit also comprises T5 Fast qPCR Mix.
Further, the application also provides application of the following primers and probes in preparing a Taqman multiplex fluorescence quantitative PCR kit for detecting porcine circovirus, wherein the primers and the probes are as follows: PCV1-F with a sequence of SEQ ID NO.1, PCV2-F with a sequence of SEQ ID NO.4, PCV3-F with a sequence of SEQ ID NO.7, PCV4-F with a sequence of SEQ ID NO.10, PCV1-R with a sequence of SEQ ID NO.2, PCV2-R with a sequence of SEQ ID NO.5, PCV3-R with a sequence of SEQ ID NO.8 and PCV4-R with a sequence of SEQ ID NO. 11; PCV1-Probe with the sequence of SEQ ID NO.3, PCV2-Probe with the sequence of SEQ ID NO.6, PCV3-Probe with the sequence of SEQ ID NO.9 and PCV4-Probe with the sequence of SEQ ID NO. 12; the 5 'end and the 3' end of the probe are respectively marked with the following fluorescent groups: PCV1-Probe: CY5 and BHQ-2, PCV2-Probe: FAM and BHQ-2, PCV3-Probe: HEX-BHQ1, PCV4-Probe: ROX and BHQ-2.
Non-diagnostic uses described herein include, but are not limited to, environmental testing, feed testing, food testing, epidemiological investigations, and the like. Samples that may be used include, but are not limited to, water, environmental sampling swabs, feces, feed products, foods of varying degrees of processing, and the like.
The types of reagents, reaction systems, and reaction parameters in the methods and kits of the present application are not limited to those shown in the summary of the invention and in the examples section, and those skilled in the art can obtain suitable types of reagents, reaction systems, and reaction parameters according to the performance and use of commercially available products and conventional knowledge in the art.
Has the beneficial effects that:
the method and the kit have the advantages that all porcine circovirus from PCV-1 to PCV-4 is detected by the detection object, the detection is completed in one 4-fold Taqman multiplex fluorescence quantitative PCR at one time, and the sensitivity and the specificity are good.
Drawings
FIG. 1 is 10 7 –10 3 Multiplex real-time fluorescent quantitative PCR amplification curve of copies/muL concentration gradient positive standard.
FIG. 2 is 10 7 –10 3 Multiplex real-time fluorescence quantitative PCR standard curve of copies/muL concentration gradient positive standard.
FIG. 3 is a multiplex real-time fluorescent quantitative PCR sensitivity experiment.
FIG. 4 shows a general PCR sensitivity experiment (1-5 4 –10 0 A positive standard substance with a copies/mu L concentration gradient; n: negative control).
FIG. 5 shows multiplex real-time fluorescent quantitative PCR specificity assays (1-7: amplification curves for PrV, ASFV, PPV, PRRSV, RV, PEDV and PK-15 cell lines, respectively; NC: negative control).
Figure 6 data of repeated experiments.
Detailed Description
The present invention will be described in detail with reference to specific examples, but the scope of the present invention is not limited to the following examples.
Example 1 primer and Probe design
And 4-8 PCV1-4 ORF2 Gene sequences separated from different countries published in NCBI GeneBank are selected, snap Gene is used for sequence comparison, a high-conservative region in ORF2 Gene is selected, oligo7 is used for primer probe design, and the designed primers are used for performing Blast comparison verification specificity on NCBI. Primer probe sequence is synthesized by Opticalceae Biotechnology Limited company, and dd H for synthesized primer probe 2 O is diluted to 10 mu mol/L and stored at 4 ℃ for later use. Through the practical verification of multiplex PCR, the following primers and probes are finally selected from 13 pairs of designed primers and 8 probes:
table 1 selected primer and probe sequences
Example 2 sample treatment and nucleic acid extraction
Adding 1mL of PBS into a sterile 2mL lysine Matrix tissue grinding tube, adding a proper amount of PCV2, PCV3, prV, ASFV, PPV, PRRSV, PRV and PEDV positive tissue samples, placing the sample in a FastPrep-24TM5G grinder, grinding for 30s, taking down the grinding tube, placing the tube in a centrifuge at 8000rpm, centrifuging for 1min, taking the supernatant, and storing at-20 ℃ for later use. The PK15 cell line, pUC57-PCV1-ORF2 and pUC57-PCV4-ORF2 were subjected to the following DNA extraction procedure without this step.
And (3) performing DNA extraction by using a Tian _ KingFisher _ Duo.bdz program by referring to the instruction of the magnetic bead method virus DNA/RNA extraction kit and matching with a KingFisher DUO automatic extraction instrument. After the procedure was completed, the eluted DNA was transferred to a 1.5mL centrifuge tube and stored at-20 ℃ for further use.
EXAMPLE 3 preparation of recombinant plasmid Standard
The TaqMan real-time fluorescent quantitative PCR primer pair designed by the experiment is used for extracting PCV1-4 DNA for common PCR amplification. The reaction conditions are as follows: 2min at 98 ℃; 35 cycles of 98 ℃ for 10s,56 ℃ for 15s, and 72 ℃ for 20 s; 5min at 72 ℃. (25. Mu.L reaction system: 1.1X gold medal Mix Ver.2. Mu.L, 10. Mu.M upstream primer 1. Mu.L, 10. Mu.M downstream primer 1. Mu.L, template DNA 1. Mu.L).
The PCR product was subjected to electrophoresis on a 3% agarose gel, set at a voltage of 120V, and run for 30min. After electrophoresis, cutting a target band, recovering and purifying according to the instruction of a DNA gel recovery kit, and immediately performing ligation transformation on a recovered product.
The recovered gel products were T-A ligated using pClone007 Simple Vector Kit to prepare 10. Mu.L of a reaction system (template 4. Mu.L), pClone007 Simple Vector 1. Mu.L), 10XTopo Mix 1. Mu.L), and ddH 2 O make up 10. Mu.L)).
The above-described ligation system was placed in a metal bath at 25 ℃ for 5min and immediately transformed after completion using Trelife TM 5. Alpha. Competent cells according to the instructions. The transformed competent cells were plated on LB medium containing Amp antibiotics and cultured at 37 ℃ for 12 hours. After the culture, a single clone was selected and inoculated in LB liquid medium, and shaken overnight at 37 ℃ and 250 rpm. The overnight cultured bacterial liquid is subjected to PCV2 and PCV3 recombinant plasmid extraction by using a high-purity plasmid DNA small-amount extraction kit according to instructions and sent to the Protechinics Biotech limited company for sequencing. The successfully ligated, sequence-free recombinant plasmids were assayed for concentration using a nucleic acid protein instrument, the copy number was calculated and 10-fold gradient dilutions were performed. The diluted plasmid is used as a positive standard substance and stored at-20 ℃ for later use. Copy number calculation formula:
copy number (copies/. Mu.L) = C.times.N A /MW
Wherein C is positive plasmid concentration with unit ng/. Mu.L, N A Take 6.02X 10 23 copies/mol, MW is the average molecular weight, in units of Dolton.
The copy numbers of PCV1-4 type plasmids are respectively as follows: PCV1 5.86X 10 11 copies/μL、PCV2 9.69×10 11 copies/μL、PCV3 6.54×10 11 copies/μL、PCV4 5.11×10 11 copies/μL。
Example 3 optimization of multiplex PCR reactions
The specific primers and the probes determined in the example 1 are used, the prepared positive standard substance is used as a template, a conventional reaction system and reaction conditions are recommended according to a reagent specification to carry out TaqMan multiplex real-time fluorescent quantitative PCR amplification, the specificity of the primers is preliminarily verified, and a basis is provided for subsequent optimization. The reaction conditions are as follows: 5min at 95 ℃; 30 cycles of 95 ℃ for 10s and 60 ℃ for 50 s. 20 μ L reaction system 2X T5 Fast qPCR Mix 10 μ L, 10 μ M upstream primer 0.8 μ L each, 10 μ M downstream primer 0.8 μ L each, 10 μ M probe 0.4 μ L each, template DNA 0.5 μ L, ddH 2 O 1.5μL。
Adding the extracted four positive templates into the same reaction system to carry out TaqMan multiplex real-time fluorescent quantitative PCR (polymerase chain reaction) primary amplification. The result shows that the negative control is established, the four positive templates have typical amplification curves, the specificity of the primer probe is good, and the reaction system can be further optimized.
Based on the reaction system and the reaction conditions, a gradient is set to optimize the annealing temperature and the cycle number, and a matrix method is adopted to optimize the primer concentration and the probe concentration. Primer final concentrations were set at 0.05. Mu.M, 0.1. Mu.M, 0.15. Mu.M, 0.2. Mu.M, 0.25. Mu.M, 0.3. Mu.M, 0.35. Mu.M, 0.4. Mu.M, 0.45. Mu.M, 0.5. Mu.M; the final concentration of the probe was set to 0.01. Mu.M, 0.05. Mu.M, 0.1. Mu.M, 0.15. Mu.M, 0.2. Mu.M, 0.25. Mu.M, 0.3. Mu.M, 0.35. Mu.M, and the annealing temperature was optimized at 65 ℃, 64 ℃, 63 ℃, 62 ℃,61 ℃,60 ℃, 59 ℃, 58 ℃ and 30, 35, and 40 cycles. Under the same template concentration, the reaction conditions with smaller Ct value are preferably selected, and if the Ct values are the same, the annealing temperature is selected to be higher.
The annealing temperature is controlled to be 59-61 ℃ under the same template concentration, the amplification efficiency and the fluorescence intensity are consistent, and the Ct value change is small. The final annealing temperature of 61 ℃ was chosen because higher annealing temperatures reduced the chance of non-specific amplification. Under the condition that other conditions are not changed, the PCV2 and PCV3 amplification reactions show different degrees of non-specific signals after the 35 th cycle, and the final selection cycle number is 35 times. And optimally screening two groups of primers and probe concentrations with high fluorescence intensity and consistent amplification efficiency by using a matrix method, and finally selecting a group of primers and probe concentrations with lower concentrations. And (3) optimizing the final concentration of the primer: PCV1, PCV3 and PCV4 are all 0.05 μ M, PCV2 is 0.15 μ M; and (3) optimizing the final concentration of the probe: PCV1-4 is 0.01. Mu.M.
The optimized 20-microliter reaction system is as follows: 2X T5 Fast qPCR Mix 10. Mu.L, 10. Mu.M PCV1, 3, 4 upstream primer 0.1. Mu.L each, 10. Mu.M PCV1, 3, 4 downstream primer 0.1. Mu.L each, 10. Mu.M PCV2 upstream primer 0.3. Mu.L, 10. Mu.M PCV2 downstream primer 0.3. Mu.L 10. Mu.M probe 0.02. Mu.L each, template DNA 0.5. Mu.L, ddH 2 O 8.22μL。
EXAMPLE 4 creation of Standard Curve
Selecting 0.5 mu L of positive standard substance with the copy number of 107-103 copies/mu L after 10 times of gradient dilution as a template, adding the template into the optimized reaction system, replacing a negative control template with ddH2O, and carrying out multiple fluorescent quantitative PCR amplification according to the optimized reaction conditions. The amplification results were analyzed using Bio-Rad CFX Maestro to establish a standard curve.
The TaqMan multiplex real-time fluorescent quantitative PCR amplification curve (figure 1) and the standard curve (figure 2) show that the Ct value (y) and the copy number (x) of the positive standard substance show good linear relation in a gradient concentration interval of 107-103 copies/mu L, and the standard curves corresponding to four target genes are respectively as follows: PCV1: y = -3.293x +36.838, R 2 =1.000, amplification efficiency (E) =101.2%; PCV2: y = -3.515x + (38.358) 2 =0.998, amplification efficiency (E) =92.5%; PCV3: y = -3.025x +36.828 2 =0.999, amplification efficiency (E) =114.1%; PCV4: y = -3.342x+38.392, R 2 =0.999, amplification efficiency (E) =99.2%.
Example 5 sensitivity, specificity, reproducibility experiments
TaqMan multiplex real-time fluorescent quantitative PCR sensitivity experiment
The copy number after 10 times of gradient dilution is selected to be 10 4 -10 0 0.5. Mu.L of positive standard substance of copies/. Mu.L is used as template, and ddH is used as negative control template 2 And O, respectively carrying out TaqMan multiplex real-time fluorescent quantitative PCR (polymerase chain reaction) amplification and common PCR amplification, and comparing the sensitivity degrees of the two methods. And respectively detecting and simultaneously detecting the positive standard substance by adopting a TaqMan multiplex real-time fluorescent quantitative PCR method, repeating the detection for 3 times, and further evaluating the influence of the simultaneous existence of various pathogens on the sensitivity.
The results in fig. 3 and 4 show that the lowest copy number detection limit of the TaqMan multiplex real-time fluorescent quantitative PCR method is: PCV 1.5.86X 10 1 copies/μL、PCV2 9.69×10 2 copies/μL、PCV36.54×10 1 copies/μL、PCV4 5.11×10 1 copies/μL。
The lowest copy number detection limits of the common PCR method are respectively: PCV1 5.86X 10 2 copies/μL、PCV2 9.69×10 3 copies/μL、PCV3 6.54×10 3 copies/μL、PCV4 5.11×10 2 copies/. Mu.L. The self-constructed TaqMan multiplex real-time fluorescent quantitative PCR method is about 10 to 100 times better than the common PCR method in the aspect of sensitivity.
TaqMan multiplex real-time fluorescent quantitative PCR specificity experiment
The method comprises the steps of taking extracted positive standard substance, porcine pseudorabies virus (PRV), african Swine Fever Virus (ASFV), porcine Parvovirus (PPV) DNA, porcine Reproductive and Respiratory Syndrome Virus (PRRSV), porcine rotavirus (PoRV) and Porcine Epidemic Diarrhea Virus (PEDV) to extract RNA, then carrying out reverse transcription to obtain cDNA and PK-15 cell line nucleic acid as templates, carrying out TaqMan multiplex real-time fluorescent quantitative PCR amplification according to an optimized reaction system and conditions, and verifying the specificity of the established TaqMan multiplex real-time fluorescent quantitative PCR method. The result of FIG. 5 shows that only PCV positive standard has a typical amplification curve, and no amplification curve appears in nucleic acids of other pathogens and cells, which indicates that the established TaqMan multiplex real-time fluorescence quantitative PCR method has good specificity.
TaqMan multiplex real-time fluorescent quantitative PCR repeatability experiment
The copy number after 10 times of gradient dilution is 10 6 -10 4 Taking a positive standard substance of copies/mu L as a template, respectively carrying out 3 times of repeated detection by using an established TaqMan multiplex real-time fluorescent quantitative PCR method, and carrying out an intra-group repeated test; taking the positive standard substance, and carrying out repeated detection on the positive standard substance for 3 times at intervals of one week under the same reaction condition to obtain a repeated test among groups. And calculating the variation coefficient between groups to verify whether the repeatability of the established TaqMan multiplex real-time fluorescence quantitative PCR method is good or not.
The results of fig. 6 show that the coefficient of variation within the group of the method is between 0.33% and 2.48%, and the coefficient of variation between the groups is between 0.53% and 3.59% (tables 2 to 7), both of which are less than 5%, indicating that the established method has better repeatability and reproducibility.
In addition, the applicant uses the kit of the present application and the existing commercially available six porcine circovirus single/multiple TaqMan real-time fluorescence quantitative detection kit for real-time detection and comparison (30 mixed samples of spleen and lymph node collected for inspection by a innocent treatment plant of Chengdu City of 2021 year 6), and the results show that the 4-fold PCR method of the present application is not inferior or even superior to the existing commercially available kit in terms of sensitivity and specificity.
Claims (10)
1. A Taqman multiplex fluorescence quantitative PCR detection method for porcine circovirus with non-diagnostic use is characterized by comprising the following primers:
PCV1-F with a sequence of SEQ ID NO.1, PCV2-F with a sequence of SEQ ID NO.4, PCV3-F with a sequence of SEQ ID NO.7, PCV4-F with a sequence of SEQ ID NO.10, PCV1-R with a sequence of SEQ ID NO.2, PCV2-R with a sequence of SEQ ID NO.5, PCV3-R with a sequence of SEQ ID NO.8 and PCV4-R with a sequence of SEQ ID NO. 11.
2. The method of claim 1, wherein the following probes are also used in the Taqman multiplex quantitative PCR: PCV1-Probe with the sequence of SEQ ID NO.3, PCV2-Probe with the sequence of SEQ ID NO.6, PCV3-Probe with the sequence of SEQ ID NO.9 and PCV4-Probe with the sequence of SEQ ID NO. 12.
3. The method of claim 2, wherein the probes are labeled at the 5 'and 3' ends with the following fluorophores, respectively: PCV1-Probe: CY5 and BHQ-2, PCV2-Probe: FAM and BHQ-2, PCV3-Probe: HEX-BHQ1, PCV4-Probe: ROX and BHQ-2.
4. The method according to any one of claims 1 to 3, wherein the Taqman multiplex quantitative PCR reaction system is 20 μ:2X T5 Fast qPCR Mix 10. Mu.L, 10. Mu.M PCV1, 3, 4 upstream primer 0.1. Mu.L each, 10. Mu.M PCV1, 3, 4 downstream primer 0.1. Mu.L each, 10. Mu.M PCV2 upstream primer 0.3. Mu.L, 10. Mu.M PCV2 downstream primer 0.3. Mu.L, 10. Mu.M probe 0.02. Mu.L each, template DNA 0.5. Mu.L, ddH 2 O 8.22μL。
5. The method of claim 4, wherein the Taqman multiplex quantitative PCR reaction program is: 5min at 95 ℃; 30 cycles of 95 ℃ for 10s and 61 ℃ for 50 s.
6. The porcine circovirus Taqman multiplex fluorescence quantitative PCR kit is characterized by comprising the following primers: PCV1-F with a sequence of SEQ ID NO.1, PCV2-F with a sequence of SEQ ID NO.4, PCV3-F with a sequence of SEQ ID NO.7, PCV4-F with a sequence of SEQ ID NO.10, PCV1-R with a sequence of SEQ ID NO.2, PCV2-R with a sequence of SEQ ID NO.5, PCV3-R with a sequence of SEQ ID NO.8 and PCV4-R with a sequence of SEQ ID NO. 11.
7. The kit of claim 6, wherein the kit further comprises the following probes: PCV1-Probe with the sequence of SEQ ID NO.3, PCV2-Probe with the sequence of SEQ ID NO.6, PCV3-Probe with the sequence of SEQ ID NO.9 and PCV4-Probe with the sequence of SEQ ID NO. 12.
8. The kit according to claim 7, wherein the probes are labeled at the 5 'and 3' ends with the following fluorophores, respectively: PCV1-Probe: CY5 and BHQ-2, PCV2-Probe: FAM and BHQ-2, PCV3-Probe: HEX-BHQ1, PCV4-Probe: ROX and BHQ-2.
9. The kit of claim 7 or 8, wherein the kit further comprises a T5 Fast qPCR Mix.
10. The application of the following primers and probes in preparing a Taqman multiplex fluorescence quantitative PCR kit for detecting porcine circovirus is characterized in that the primers and the probes are as follows: PCV1-F with a sequence of SEQ ID NO.1, PCV2-F with a sequence of SEQ ID NO.4, PCV3-F with a sequence of SEQ ID NO.7, PCV4-F with a sequence of SEQ ID NO.10, PCV1-R with a sequence of SEQ ID NO.2, PCV2-R with a sequence of SEQ ID NO.5, PCV3-R with a sequence of SEQ ID NO.8 and PCV4-R with a sequence of SEQ ID NO. 11; PCV1-Probe with the sequence of SEQ ID NO.3, PCV2-Probe with the sequence of SEQ ID NO.6, PCV3-Probe with the sequence of SEQ ID NO.9 and PCV4-Probe with the sequence of SEQ ID NO. 12; the 5 'end and the 3' end of the probe are respectively marked with the following fluorescent groups: PCV1-Probe: CY5 and BHQ-2, PCV2-Probe: FAM and BHQ-2, PCV3-Probe: HEX-BHQ1, PCV4-Probe: ROX and BHQ-2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210741678.XA CN115478118A (en) | 2022-06-28 | 2022-06-28 | Taqman multiplex fluorescence quantitative PCR (polymerase chain reaction) detection method for porcine circovirus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210741678.XA CN115478118A (en) | 2022-06-28 | 2022-06-28 | Taqman multiplex fluorescence quantitative PCR (polymerase chain reaction) detection method for porcine circovirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115478118A true CN115478118A (en) | 2022-12-16 |
Family
ID=84421907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210741678.XA Pending CN115478118A (en) | 2022-06-28 | 2022-06-28 | Taqman multiplex fluorescence quantitative PCR (polymerase chain reaction) detection method for porcine circovirus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115478118A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103305638A (en) * | 2013-02-21 | 2013-09-18 | 北京世纪元亨动物防疫技术有限公司 | Dual real-time fluorescence PCR (Polymerase Chain Reaction) detection primer pair, probes, kit and detection method for type 1 and type 2 porcine circovirus |
| CN105969910A (en) * | 2015-12-25 | 2016-09-28 | 四川农业大学 | Multiple GeXP-PCR method for detecting reproductive failure diseases of pigs |
| CN108265126A (en) * | 2018-01-12 | 2018-07-10 | 温州大学 | The foundation of 3 type of pig circular ring virus and porcine circovirus 2 type duplex PCR detection method |
| CN111763771A (en) * | 2020-07-18 | 2020-10-13 | 扬州大学 | Quadruple real-time fluorescent PCR (polymerase chain reaction) identification and detection method for porcine circovirus types 1 to 4 |
| KR102208001B1 (en) * | 2020-01-31 | 2021-01-27 | 대한민국 | Composition for simultaneous detection of porcine circovirus type 2 and type 3 and use thereof |
| CN113249524A (en) * | 2021-06-25 | 2021-08-13 | 广东省农业科学院动物卫生研究所 | Triple real-time fluorescent quantitative PCR primer and probe composition for detecting various porcine circovirus and application thereof |
-
2022
- 2022-06-28 CN CN202210741678.XA patent/CN115478118A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103305638A (en) * | 2013-02-21 | 2013-09-18 | 北京世纪元亨动物防疫技术有限公司 | Dual real-time fluorescence PCR (Polymerase Chain Reaction) detection primer pair, probes, kit and detection method for type 1 and type 2 porcine circovirus |
| CN105969910A (en) * | 2015-12-25 | 2016-09-28 | 四川农业大学 | Multiple GeXP-PCR method for detecting reproductive failure diseases of pigs |
| CN108265126A (en) * | 2018-01-12 | 2018-07-10 | 温州大学 | The foundation of 3 type of pig circular ring virus and porcine circovirus 2 type duplex PCR detection method |
| KR102208001B1 (en) * | 2020-01-31 | 2021-01-27 | 대한민국 | Composition for simultaneous detection of porcine circovirus type 2 and type 3 and use thereof |
| CN111763771A (en) * | 2020-07-18 | 2020-10-13 | 扬州大学 | Quadruple real-time fluorescent PCR (polymerase chain reaction) identification and detection method for porcine circovirus types 1 to 4 |
| CN113249524A (en) * | 2021-06-25 | 2021-08-13 | 广东省农业科学院动物卫生研究所 | Triple real-time fluorescent quantitative PCR primer and probe composition for detecting various porcine circovirus and application thereof |
Non-Patent Citations (4)
| Title |
|---|
| NANHUA CHEN，等: "Development and application of a quadruplex real-time PCR assay for differential detection of porcine circoviruses (PCV1 to PCV4) in Jiangsu province of China from 2016 to 2020", TRANSBOUND. EMERG. DIS., vol. 68, no. 3, 31 May 2021 (2021-05-31), pages 1615 - 1624 * |
| 吴江，等: "PCV2 型和 PCV3 型双重荧光定量 PCR 检测方法的建立", 中国兽医科学, vol. 51, no. 09, 31 March 2021 (2021-03-31), pages 1121 - 1127 * |
| 易道生;娄高明;韩先干;冯顺胜;: "猪圆环病毒多重PCR检测与分型", 安徽农业科学, vol. 35, no. 32, 20 November 2007 (2007-11-20), pages 10239 - 10241 * |
| 李原野，等: "猪细小病毒与圆环病毒3型双重PCR方法的建立与应用", 四川畜牧兽医, no. 10, 31 December 2020 (2020-12-31), pages 24 - 29 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110408726B (en) | Method for detecting 29 respiratory pathogens by using Taqman low-density microfluidic chip technology | |
| CN110760620A (en) | Classical swine fever virus and African classical swine fever virus dual-fluorescence PCR detection reagent, kit and detection method | |
| CN111020062A (en) | Triple real-time fluorescent quantitative PCR kit for detecting African swine fever wild strain and gene deletion strain | |
| CN113718045B (en) | DNA fragment, primer, probe and kit for detecting 4 kinds of Bordetella pertussis and specifically detecting Bordetella pertussis and application | |
| CN111763771A (en) | Quadruple real-time fluorescent PCR (polymerase chain reaction) identification and detection method for porcine circovirus types 1 to 4 | |
| CN112522447A (en) | Absolute fluorescence quantitative PCR detection method for chicken infectious anemia virus | |
| CN113564280A (en) | RAA primer for detecting 12 serotypes of avian adenovirus group I and detection method thereof | |
| CN108707697B (en) | LAMP (loop-mediated isothermal amplification) detection primer pair and detection method for seneca valley virus | |
| CN112646931A (en) | Primer pair, probe, kit and detection method for detecting porcine circovirus type 4 | |
| CN110438264B (en) | Method for detecting porcine epidemic diarrhea virus and B-type porcine enterovirus by using double real-time fluorescence quantitative RT-PCR | |
| CN110607398B (en) | RT-LAMP kit for fluorescent visual rapid detection of porcine epidemic diarrhea virus | |
| Wang et al. | Comparison of multiplex real-time PCR and PCR-reverse blot hybridization assays for the direct and rapid detection of porcine circovirus type 2 genotypes | |
| CN115478118A (en) | Taqman multiplex fluorescence quantitative PCR (polymerase chain reaction) detection method for porcine circovirus | |
| CN111500774B (en) | Epidemic hemorrhagic disease virus and serotype identification RT-PCR kit | |
| CN110735005A (en) | SIV and PRRSV multiple RT-PCR rapid detection kit and primer | |
| CN112063757A (en) | Primer and kit for detecting African swine fever virus and application of primer and kit | |
| CN111235317A (en) | Primer composition, kit and method for detecting PRRSV (porcine reproductive and respiratory syndrome Virus) and PCV (porcine circovirus Virus) | |
| CN112646930A (en) | Primer pair, probe, kit and detection method for detecting porcine circovirus type 3 | |
| CN111621578A (en) | RU 61-00441 gene-based Salmonella spelt constant-temperature detection kit and method | |
| CN113025754A (en) | Nucleic acid composition, kit and detection method for detecting feline anemia pathogens | |
| CN107513563B (en) | SYBR Green I fluorescent quantitative PCR kit for detecting salmonella pullorum and application thereof | |
| CN113718044A (en) | Primer, probe and kit for fluorescent quantitative detection of swine mycoplasma, mycoplasma microformis and new mycoplasma haemophilus | |
| CN114317833B (en) | Primer for rapidly distinguishing porcine circovirus type 1, type 2b and chimeric porcine circovirus C1-233 strain and application thereof | |
| CN115976273B (en) | Dual fluorescence PCR detection kit for identifying African swine fever virus genes type I and type II | |
| CN110512017B (en) | Mouse corynebacterium fluorescent quantitative PCR detection kit and primer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |